Risk Of Thrombosis In Elderly Immune Primary Trombocytopenic Patients Treated with Thrombopoietin Receptors Agonists

Why do patients with immune thrombocytopenia (ITP) experience lower bleeding events despite thrombocytopenia?

(2020) Renee Boulware et al.   THROMBOSIS RESEARCH

Platelet Apoptosis and PAI-1 are Involved in the Pro-Coagulant State of Immune Thrombocytopaenia Patients Treated with Thrombopoietin Receptor Agonists

(2019) Raul Justo Sanz et al.   THROMBOSIS AND HAEMOSTASIS

Cardiovascular and bleeding outcomes in a population‐based cohort of patients with chronic immune thrombocytopenia

(2019) Kasper Adelborg et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Is ITP a thrombophilic disorder?

(2015) Francesco Rodeghiero   AMERICAN JOURNAL OF HEMATOLOGY

Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group

(2013) F. Rodeghiero et al.   BLOOD

Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP

(2008) J. B. Bussel et al.   BLOOD